文献速递生殖医学

抗苗勒管激素信号通路基因多态性与卵巢功能的关联:系统综述与荟萃分析

Association of gene polymorphisms in the anti-Müllerian hormone signalling pathway with ovarian function: a systematic review and meta-analysis.
PubMed 文献 · Reprod Biomed Online · 2019-04-26

该系统综述与荟萃分析纳入8项研究共3155名参与者进行荟萃分析,另10项研究作描述性分析,评估AMH与AMHRII基因单核苷酸多态性与卵巢功能的关联。AMH c.146T>G不同基因型间血清AMH水平无显著差异(WMD 0.42,95%CI -0.16至0.99);AMHRII -482 A>G的A/A与G/A或G/G基因型携带者间血清AMH水平无显著差异(WMD -0.04,95%CI -0.31至0.23),亚组分析中健康女性与多囊卵巢综合征患者呈现有趣趋势。综述提示AMH c.146T>G与AMH水平无关,而AMHRII -482 A>G可能与PCOS及健康亚组的AMH水平相关,但AMH信号通路多态性对卵巢功能的影响仍需进一步研究。

要点

  • AMH c.146T>G不同基因型间血清AMH水平无显著差异(WMD 0.42,95%CI -0.16至0.99)。
  • AMHRII -482 A>G的A/A与G/A或G/G基因型携带者间血清AMH水平无显著差异(WMD -0.04,95%CI -0.31至0.23)。
  • 亚组分析中健康女性WMD -0.36(95%CI -0.63至-0.09,P=0.009),PCOS患者WMD 0.46(95%CI 0.15至0.77,P=0.004)。

核心结论

  • AMH c.146T>G与血清AMH水平无关。
  • AMHRII -482 A>G可能与PCOS和健康亚组的AMH水平相关。
  • AMH信号通路多态性对卵巢功能的影响仍需进一步研究。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed和Embase并手工检索参考文献列表。
  • 8项研究共3155名参与者纳入荟萃分析,10项研究纳入描述性分析。

主要发现

  • AMH c.146T>G不同基因型间血清AMH水平无显著差异(WMD 0.42,95%CI -0.16至0.99)。
  • 欧洲地区及健康与不孕人群中亚组分析结果相似。
  • AMHRII -482 A>G的A/A基因型与G/A或G/G基因型携带者间血清AMH水平无显著差异(WMD -0.04,95%CI -0.31至0.23)。
  • 亚组分析中健康女性WMD -0.36(95%CI -0.63至-0.09,P=0.009),PCOS患者WMD 0.46(95%CI 0.15至0.77,P=0.004)。

局限性

  • AMH信号通路多态性对卵巢功能的影响仍需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This systematic review evaluated whether single nucleotide polymorphisms of AMH and AMHRII genes are associated with ovarian function. A literature search of PubMed and Embase was complemented by hand searches in the reference lists. Eight studies involving 3155 participants were included in a meta-analysis and 10 studies included for description. For AMH c.146T>G polymorphism, no significant difference in serum anti-Müllerian hormone (AMH) levels was found between participants with different genotypes (weighted mean difference [WMD] 0.42, 95% confidence interval [CI] -0.16 to 0.99). Subgroup analyses showed similar results for the European region and in healthy and infertile populations. Regarding AMHRII -482 A>G, there was no significant difference in serum AMH levels between participants with A/A genotype and G/A or G/G genotype carriers (WMD -0.04, 95% CI -0.31 to 0.23). In subgroup analysis, an interesting trend was confirmed in healthy women and polycystic ovary syndrome (PCOS) patients (WMD -0.36, 95% CI -0.63 to -0.09, P = 0.009; WMD 0.46, 95% CI 0.15 to 0.77, P = 0.004). The review suggests that AMH c.146T>G is not associated with AMH levels, while AMHRII -482 A>G may be related to AMH levels in PCOS and healthy subgroups. However, the impact of polymorphisms in the AMH signalling pathway on ovarian function still requires further investigation.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Cheng R, Xiong W, Luo X, et al. Association of gene polymorphisms in the anti-Müllerian hormone signalling pathway with ovarian function: a systematic review and meta-analysis. Reprod Biomed Online. 2019. PMID: 31253588. doi:10.1016/j.rbmo.2019.04.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。